TradingKey

关于 PolyPid Ltd 公司

Polypid Ltd 是一家位于以色列的临床阶段生物制药公司。该公司专注于开发、生产和商业化新型局部给药疗法，以改善手术效果。主要产品是 PLEX 技术，该技术位于手术部位，可确保药物的受控和持续输送。

公司简介

公司代码PYPD

公司名称PolyPid Ltd

上市日期Jun 26, 2020

CEOMs. Dikla Czaczkes Akselbrad

员工数量57

证券类型Ordinary Share

年结日Jun 26

公司地址18 Hasivim Street, P.O Box 7126

城市PETAH TIKVA

上市交易所NASDAQ Capital Market Consolidated

国家Israel

邮编4917002

电话972747195700

网址https://www.polypid.com

公司代码PYPD

上市日期Jun 26, 2020

CEOMs. Dikla Czaczkes Akselbrad

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. Yechezkel Barenholz, Ph.D.

Independent Director

2.76K

--

Ms. Dikla Czaczkes Akselbrad

Chief Executive Officer, Director

934.00

+100.00%

Dr. Itzhak Krinsky, Ph.D.

Independent Director

833.00

--

Mr. Jacob Harel

Independent Chairman of the Board

467.00

--

Mr. Ori Warshavsky

Chief Operating Officer - US

267.00

--

Mr. Chaim Hurvitz

Independent Director

--

Dr. Shaul Mukhtar, Ph.D.

Chief Operating Officer, Executive Vice President

--

Ms. Dalit Hazan

Senior Vice President - Research and Development and Regulatory Affairs

--

Dr. Noam Emanuel, Ph.D.

Chief Scientific Officer

--

Dr. Robert Burton (Bob) Stein, M.D., Ph.D.

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Dr. Yechezkel Barenholz, Ph.D.

Independent Director

2.76K

--

Ms. Dikla Czaczkes Akselbrad

Chief Executive Officer, Director

934.00

+100.00%

Dr. Itzhak Krinsky, Ph.D.

Independent Director

833.00

--

Mr. Jacob Harel

Independent Chairman of the Board

467.00

--

Mr. Ori Warshavsky

Chief Operating Officer - US

267.00

--

Mr. Chaim Hurvitz

Independent Director

--

收入明细

暂无数据

暂无数据

业务

地区

暂无数据

股东统计

更新时间: 5月16日周五

持股股东

股东类型

持股股东

占比

Aurum Ventures M.K.I.

19.88%

Centaurus Investments Limited

10.87%

Rosalind Advisors, Inc.

9.99%

Nir (Yehuda)

6.02%

Hewlett Fund, L.P.

5.77%

Other

47.47%

持股股东

占比

Aurum Ventures M.K.I.

19.88%

Centaurus Investments Limited

10.87%

Rosalind Advisors, Inc.

9.99%

Nir (Yehuda)

6.02%

Hewlett Fund, L.P.

5.77%

Other

47.47%

股东类型

持股股东

占比

Venture Capital

19.88%

Hedge Fund

19.57%

Holding Company

10.87%

Individual Investor

9.02%

Corporation

5.77%

Investment Advisor/Hedge Fund

4.75%

Private Equity

4.54%

Investment Advisor

0.28%

Research Firm

0.02%

Other

25.31%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

41

7.61M

74.69%

+1.40M

2025Q1

42

7.66M

75.16%

+942.60K

2024Q4

44

5.48M

65.20%

+1.87M

2024Q3

50

4.47M

69.98%

+1.49M

2024Q2

58

3.43M

73.51%

+1.59M

2024Q1

59

3.33M

71.29%

+2.56M

2023Q4

54

443.78K

34.10%

+80.67K

2023Q3

57

479.04K

37.01%

+97.48K

2023Q2

57

472.86K

36.65%

+91.51K

2023Q1

59

332.36K

28.62%

+89.40K

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Aurum Ventures M.K.I.

2.03M

19.88%

+11.34K

+0.56%

Feb 26, 2025

Centaurus Investments Limited

1.11M

10.87%

+475.10K

+75.12%

Dec 31, 2024

Rosalind Advisors, Inc.

1.02M

9.99%

--

Mar 31, 2025

Nir (Yehuda)

613.91K

6.02%

+62.60K

+11.36%

Mar 31, 2025

Hewlett Fund, L.P.

587.92K

5.77%

+338.44K

+135.66%

Feb 26, 2025

Triple Gate Capital, LP

465.84K

4.57%

+465.84K

--

Feb 26, 2025

AIGH Capital Management, LLC.

510.95K

5.01%

-507.07K

-49.81%

Mar 31, 2025

Worth Venture Partners, LLC

429.43K

4.21%

+153.81K

+55.80%

Mar 31, 2025

Lukach (Aharon)

299.55K

2.94%

-5.64K

-1.85%

Mar 31, 2025

Dafna Capital Management, LLC

291.27K

2.86%

--

Mar 31, 2025

持股ETF

机构名称

占比

暂无数据

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

Aug 30, 2023

Merger

30<1

Aug 30, 2023

Merger

30<1

Aug 30, 2023

Merger

30<1

Aug 30, 2023

Merger

30<1

公告日期

类型

比率

Aug 30, 2023

Merger

30<1

Aug 30, 2023

Merger

30<1

Aug 30, 2023

Merger

30<1

Aug 30, 2023

Merger

30<1

PolyPid Ltd

3.546USD

PolyPid Ltd

3.546

概览

公司

财务